MYCN and neuroblastoma: We further explored whether expression of these markers was dependent on the genetic subtype and evaluated our RNA-seq dataset for DTC marker expression in neuroblastoma with and without MYCN-amplification, loss of chromosome 11q or other neuroblastoma-specific genetic aberrations (Figure 4d and Figure S15).